Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fallopian Tube Neoplasms × pertuzumab × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 24 Neoplasms 5 Neoplasm Metastasis 3 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Inflammatory Breast Neoplasms 2 HER2-positive Early Breast Cancer 2 HER2-positive Breast Cancer 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Anatomic Stage I Breast Cancer AJCC v8 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Solid Cancer 1 Resectable HER2-positive Breast Cancer 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Patient Preference 1 Pathologic Complete Response 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Malignant Solid Neoplasm 1 Liver Neoplasms 1 Hemangiosarcoma 1 HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients 1 HER2-positive Early-stage Breast Cancer 1 Gastrointestinal Neoplasms 1 Early-stage or Locally Advanced HER2-positive Breast Cancer 1

Interventions

Paclitaxel 16 Carboplatin 16 Bevacizumab 15 olaparib 13 Specimen Handling 12 Taxes 10 Magnetic Resonance Spectroscopy 10 Biopsy 8 liposomal doxorubicin 7 Gemcitabine 6 pembrolizumab 5 mirvetuximab soravtansine 5 Immunoglobulin G 5 Disulfides 5 niraparib 4 cediranib 4 Doxorubicin 4 Cisplatin 4 Platinum 3 Drug Therapy 3 Docetaxel 3 130-nm albumin-bound paclitaxel 3 atezolizumab 2 adavosertib 2 X-Rays 2 Topotecan 2 Standard of Care 2 Injections 2 Hyperthermic Intraperitoneal Chemotherapy 2 Aspirin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡